AlloBMT should be option for older adults with hematologic malignanciesFebruary 24, 2019Transplantation
MRD negativity linked to survival in MM after auto-HCTFebruary 24, 2019TransplantationMultiple MyelomaLymphoma & Plasma Cell Disorders
Treosulfan may become standard in allo-HCT for AML/MDSFebruary 23, 2019TransplantationAMLLeukemia, Myelodysplasia, Transplantation
Ultrasound method predicts liver complications in pediatric transplantFebruary 23, 2019TransplantationPediatrics
Similar results for once- or twice-weekly carfilzomib in MMFebruary 23, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Regimen shows promise as salvage for classical HLFebruary 22, 2019Hodgkin LymphomaLymphoma & Plasma Cell Disorders
FDA clears test to monitor residual disease in CMLFebruary 22, 2019CMLLeukemia, Myelodysplasia, Transplantation
FDA grants priority review to polatuzumab vedotin for DLBCLFebruary 20, 2019Lymphoma & Plasma Cell Disorders
Researchers characterize new subtype of high-grade DLBCLFebruary 17, 2019Lymphoma & Plasma Cell DisordersAggressive Lymphomas
